Sandoz Group AG (SWX:SDZ)
62.66
-0.18 (-0.29%)
Apr 28, 2026, 5:30 PM CET
Sandoz Group AG Revenue
In the year 2025, Sandoz Group AG had annual revenue of $11.16B USD with 7.44% growth. Sandoz Group AG had revenue of $5.89B in the half year ending December 31, 2025, with 16.70% growth.
Revenue
$11.16B
Revenue Growth
+7.44%
P/S Ratio
3.06
Revenue / Employee
$499.06K
Employees
22,356
Market Cap
27.11B CHF
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Galderma Group AG | 4.16B |
| Lonza Group AG | 6.53B |
| Alcon | 8.25B |
| Straumann Holding AG | 2.61B |
| Sonova Holding AG | 3.85B |
| Galenica AG | 4.15B |
Sandoz Group AG News
- 13 days ago - Sandoz Signs Rwanda Deal To Expand Access To Affordable Medicines Across Africa - Nasdaq
- 2 months ago - Sandoz Shares Jump on Improved Guidance - WSJ
- 2 months ago - Sandoz Group AG Earnings Call Transcript: Q4 2025 - Transcripts
- 3 months ago - Sandoz Group AG Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 5 months ago - Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz - Accesswire
- 5 months ago - Sandoz Group AG Transcript: Jefferies London Healthcare Conference 2025 - Transcripts
- 5 months ago - Sandoz CEO expects Ozempic biosimilars to enter Canadian market in Q1, Q2 - Reuters
- 5 months ago - EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A - PRNewsWire